Dabur Sees Mid-Single Digit Q4 Growth on Domestic Recovery, Mixed Global Trends

Dabur India expects mid-single digit consolidated revenue growth in Q4 FY26, driven by a sequential recovery in the domestic market, where its FMCG business is likely to grow in the high single digits. Strong performance in home and personal care — led by Amla, Vatika, Odonil, and Real Activ — with growth in the twenties, supported overall momentum. The healthcare segment saw double-digit growth in key products like Dabur Honey, Honitus, and Hajmola, though hydration portfolio weakness (e.g., Glucose) due to unseasonal rains limited overall expansion to low single digits. Internationally, West Asia remained weak due to geopolitical tensions, but markets like Turkey, Bangladesh, and the UK posted double-digit growth in constant currency. Overall international revenue is expected to grow in low single digits in rupee terms, contributing ~25% of total revenues. Cost controls and improved product mix are expected to drive operating profit growth ahead of revenue. Organised channels and e-commerce grew well, while general trade showed signs of revival. Looking ahead, Dabur remains optimistic about sustained domestic recovery but cautious on global risks. Full financial results will be announced post-board approval.